SCHEMBL29460216

SCHEMBL29460216

O=C(NCC1CC/C(=C/CO)C1)c1cc2ccccc2[nH]1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SCN4A P35499 1/20 0.60
▸ SCN9A Q15858 1/20 0.60
▸ SCN3A Q9NY46 1/20 0.60
▸ DRD2 P14416 2/20 0.55
▸ DRD3 P35462 2/20 0.55
▸ KDM4E B2RXH2 5/20 0.53
▸ HSD17B10 Q99714 3/20 0.53
▸ HPGD P15428 1/20 0.53
▸ ALDH1A1 P00352 2/20 0.50
▸ AKR1C3 P42330 1/20 0.48
▸ GAA P10253 1/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ HTR2C P28335 1/20 0.46
▸ HDAC3 O15379 1/20 0.45
▸ HDAC4 P56524 1/20 0.45
▸ HDAC1 Q13547 1/20 0.45
▸ HDAC7 Q8WUI4 1/20 0.45
▸ HDAC2 Q92769 1/20 0.45
▸ HDAC10 Q969S8 1/20 0.45
▸ HDAC11 Q96DB2 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22534019 1.00 SCN4A (0.60) SCN4ASCN9ASCN3ADRD2DRD3
SCHEMBL22534018 1.00 SCN4A (0.60) SCN4ASCN9ASCN3ADRD2DRD3
SCHEMBL22533895 0.83 SCN4A (0.65) SCN4ASCN9ASCN3ADRD2DRD3
SCHEMBL6885051 0.81 KDM4E (0.67) SCN4ASCN9ASCN3ADRD2DRD3
SCHEMBL6883734 0.79 KDM4E (0.68) SCN4ASCN9ASCN3ADRD2DRD3
SCHEMBL6885191 0.79 KDM4E (0.68) SCN4ASCN9ASCN3ADRD2DRD3
SCHEMBL75509 0.78 KDM4E (0.67) SCN4ASCN9ASCN3ADRD2DRD3
SCHEMBL18767312 0.77 MAOB (0.67) SCN4ASCN9ASCN3ADRD2DRD3
SCHEMBL22534020 0.75 MAOB (0.60) SCN4ASCN9ASCN3ADRD2DRD3
SCHEMBL18767964 0.74 SLC6A2 (0.59) SCN4ASCN9ASCN3ADRD2DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3953350-A1 D3 RECEPTOR AGONIST COMPOUNDS; METHODS OF PREPARATION; INTERMEDIATES THEREOF; AND METHODS OF USE THEREOF The United States of America, as Represented by The Department of Health and Human Services (US) 2022-02-16 — — EP disclosed
Send feedback